Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized controlled trial of presatovir in lung transplant recipients with RSV infection
2015-002287-16Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus disease (RSV) comparing presatovir with placebo (2 arms). Primary endpoints: Nasal RSV viral load and Clinical sequelae and lung function. Started Aug 2015; status: completed.
02
Drugs
presatovir
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on 2015-002287-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002287-16.